Reversible cerebral lesions associated with tiazofurin usage: MR demonstration

David J. Rippe, Mary K. Edwards, Jerome F. Schrodt, James R. Bognanno, Peter G. D’Amour, Orest Boyko

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. We report our results with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR were correlated with findings on CT as well as with cerebral angiography. The utility of MR in the evaluation of patients receiving this new agent is illustrated.

Original languageEnglish (US)
Pages (from-to)1078-1081
Number of pages4
JournalJournal of Computer Assisted Tomography
Volume12
Issue number6
StatePublished - 1988
Externally publishedYes

Fingerprint

tiazofurin
Magnetic Resonance Spectroscopy
Cerebral Angiography
Pharmaceutical Preparations

Keywords

  • Abnormalities
  • Brain
  • Complications
  • Drugs
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Rippe, D. J., Edwards, M. K., Schrodt, J. F., Bognanno, J. R., D’Amour, P. G., & Boyko, O. (1988). Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. Journal of Computer Assisted Tomography, 12(6), 1078-1081.

Reversible cerebral lesions associated with tiazofurin usage : MR demonstration. / Rippe, David J.; Edwards, Mary K.; Schrodt, Jerome F.; Bognanno, James R.; D’Amour, Peter G.; Boyko, Orest.

In: Journal of Computer Assisted Tomography, Vol. 12, No. 6, 1988, p. 1078-1081.

Research output: Contribution to journalArticle

Rippe, DJ, Edwards, MK, Schrodt, JF, Bognanno, JR, D’Amour, PG & Boyko, O 1988, 'Reversible cerebral lesions associated with tiazofurin usage: MR demonstration', Journal of Computer Assisted Tomography, vol. 12, no. 6, pp. 1078-1081.
Rippe DJ, Edwards MK, Schrodt JF, Bognanno JR, D’Amour PG, Boyko O. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. Journal of Computer Assisted Tomography. 1988;12(6):1078-1081.
Rippe, David J. ; Edwards, Mary K. ; Schrodt, Jerome F. ; Bognanno, James R. ; D’Amour, Peter G. ; Boyko, Orest. / Reversible cerebral lesions associated with tiazofurin usage : MR demonstration. In: Journal of Computer Assisted Tomography. 1988 ; Vol. 12, No. 6. pp. 1078-1081.
@article{0a157c7cbffc409daabdadb6535c2f10,
title = "Reversible cerebral lesions associated with tiazofurin usage: MR demonstration",
abstract = "Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. We report our results with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR were correlated with findings on CT as well as with cerebral angiography. The utility of MR in the evaluation of patients receiving this new agent is illustrated.",
keywords = "Abnormalities, Brain, Complications, Drugs, Magnetic resonance imaging",
author = "Rippe, {David J.} and Edwards, {Mary K.} and Schrodt, {Jerome F.} and Bognanno, {James R.} and D’Amour, {Peter G.} and Orest Boyko",
year = "1988",
language = "English (US)",
volume = "12",
pages = "1078--1081",
journal = "Journal of Computer Assisted Tomography",
issn = "0363-8715",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Reversible cerebral lesions associated with tiazofurin usage

T2 - MR demonstration

AU - Rippe, David J.

AU - Edwards, Mary K.

AU - Schrodt, Jerome F.

AU - Bognanno, James R.

AU - D’Amour, Peter G.

AU - Boyko, Orest

PY - 1988

Y1 - 1988

N2 - Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. We report our results with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR were correlated with findings on CT as well as with cerebral angiography. The utility of MR in the evaluation of patients receiving this new agent is illustrated.

AB - Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. We report our results with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR were correlated with findings on CT as well as with cerebral angiography. The utility of MR in the evaluation of patients receiving this new agent is illustrated.

KW - Abnormalities

KW - Brain

KW - Complications

KW - Drugs

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=0023755875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023755875&partnerID=8YFLogxK

M3 - Article

C2 - 3183120

AN - SCOPUS:0023755875

VL - 12

SP - 1078

EP - 1081

JO - Journal of Computer Assisted Tomography

JF - Journal of Computer Assisted Tomography

SN - 0363-8715

IS - 6

ER -